Sofia, Bulgaria, June 9, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 6, 2025 the Company sold 3 310 (three thousand three hundred and ten) repurchased own shares representing 0.002% of the share capital of the Company, at a total value of BGN 21 581.80 on the Bulgarian Stock Exchange, the average price per share was BGN 6.52.

Sofia, Bulgaria, June 6, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 5, 2025 the Company sold 13 660 (thirteen thousand six hundred and sixty) repurchased own shares representing 0.008% of the share capital of the Company, at a total value of BGN 89 469.60 on the Bulgarian Stock Exchange, the average price per share was BGN 6.55.

Sofia, Bulgaria, June 5, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 4, 2025 the Company sold 42 210 (forty-two thousand two hundred and ten) repurchased own shares representing 0.02% of the share capital of the Company, at a total value of BGN 278 870,64 on the Bulgarian Stock Exchange, the average price per share was BGN 6,61.

Sofia, Bulgaria, June 4, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 3, 2025 the Company sold 12 000 (twelve thousand) repurchased own shares representing 0.007% of the share capital of the Company, at a total value of BGN 80 440 on the Bulgarian Stock Exchange, the average price per share was BGN 6,70.